Skip to content

Intermittent Fasting (IF) Has Gained Recognition as a Promising Weight Loss Approach That Improves Body Weight, Insulin Resistance, and Metabolism. While Standard Diets Are Common in PCOS Management, IF May Address the Underlying Causes of Weight Gain and Offer Additional Metabolic Benefits

Effects of Different Dietary Programs on Anthropometric Parameters in Women With Polycystic Ovary Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06804044
Enrollment
33
Registered
2025-01-31
Start date
2022-11-30
Completion date
2024-01-24
Last updated
2025-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caloric Restriction, Intermittent Fasting, Medical Nutrition Therapy, Polycystic Ovary Syndrome, Weight Loss

Keywords

Diet, PCOS, IF

Brief summary

The goal of this clinical trial is to learn if dietary interventions works to improve anthropometric measures in women with PCOS. The main questions it aims to answer are: * Does intermittent fasting (IF) cause loss of body weight, fat and muscle mass? * Can IF be considered more effective to medical and standart nutrition therapy (SDT)? * What dietary problems do participants have when having IF diet? Participants will: * Follow IF, SDT, or no intervention for 8 weeks. * Visit the clinic once every 2 weeks for check ups with a total of 5 visits for intervention groups IF and STD, visit at the beginning, second week and at the end for control group * Keep dietary records

Detailed description

It was conducted in individuals who were diagnosed with PCOS as a result of clinical, biochemical and ultrasonographic medical evaluation by a gynecologist.

Interventions

BEHAVIORALIntermittent Fasting

A 16:8 intermittent fasting with a daytime eating window model was applied.

BEHAVIORALStandart Diet Therapy

Meal plan with 3 main meals and 3 snacks was applied.

Sponsors

Bahçeşehir University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized controlled trial

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Voluntariness to participate in the study * BMI between 25-35 kg/m2 * Women between the ages of 18-45

Exclusion criteria

* An endocrine disorder other than polycystic ovary syndrome * Chronic liver and kidney disease, * Diabetes, * Hypertension, * Hyperuricemia, * Heart Failure, * Thyroid disease, * Pregnant and breastfeeding women, * Individuals with psychiatric disorders, * Oncological diseases, * Women using medication, * Those with pacemakers and platinum, * Those with special nutritional needs

Design outcomes

Primary

MeasureTime frameDescription
Body Weight lose8 weeksTotal body weight (kg)
Body Composition: Fat, Muscle8 weeksBody Muscle= skeletal muscle mass (kg), regional muscle analysis (right-left arm, trunk, right-left leg) (kg). Body Fat= fat mass (kg), regional fat analysis (right-left arm, trunk, right-left leg) (kg).
Body Circumference Measurements8 weeksWaist Circumference, Hip Circumference, Upper Arm Circumference, Neck Circumference

Secondary

MeasureTime frameDescription
Dietary Energy Intakes8 weeksEnergy (kcal),
Energy Ratio from Macronutrients8 weeksCarbohydrate energy %, Protein energy % ,Fat energy %
Body Mass Indeks8 weeksweight (kg) and height (cm) will be combined to report BMI in kg/m\^2
Dietary Micronutrients Intakes8 weeksMicronutrents: Vitamin and Mineral intakes will be presented as a percentage (%) of meeting the daily recommended intake.
Dietary Macronutrients Intakes8 weeksMacronutrients: carbohydrates (g), proteins (g), fats (g)
Body Fat Ratio8 weekstotal fat ratio (%)
Body Water8 weeksBody water (ml)

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026